Sintx Technologies (SINT) EBITDA Margin Growth (5y) (2018 - 2026)
Powered by 
Analysis
Sintx Technologies (SINT) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 196,892.00 |
| Dec 31, 2025 | 113,000.00 |
| Sep 30, 2025 | 206,581.00 |
| Jun 30, 2025 | -79,235.00 |
| Mar 31, 2025 | 24,985.00 |
| Dec 31, 2024 | 33,163.00 |
| Sep 30, 2024 | 18,066.00 |
| Jun 30, 2024 | 59,589.00 |
| Mar 31, 2024 | 131,815.00 |
| Jun 30, 2023 | -58,861.00 |
| Mar 31, 2023 | -56,254.00 |
| Dec 31, 2022 | -29,792.00 |
| Sep 30, 2022 | -58,885.00 |
| Jun 30, 2022 | -110,584.00 |
| Mar 31, 2022 | -216,401.00 |
| Dec 31, 2021 | -147,876.00 |
| Sep 30, 2021 | -108,707.00 |
| Jun 30, 2021 | -227,744.00 |
| Mar 31, 2021 | -275,335.00 |
| Dec 31, 2020 | -187,763.00 |